InvestorsHub Logo
icon url

pgsd

10/12/22 10:49 AM

#521284 RE: iwasadiver #521279

I personally think you have pretty much nailed it and agree. As somebody who prefers partnerships to a buyout (at this time) I am fine with this. Contrary to what some believe, there is no way LP will let this platform go for 'peanuts' and that is what Merck are probably trying to offer :-)
icon url

dr_lowenstein

10/12/22 10:51 AM

#521286 RE: iwasadiver #521279

Wow so LP toldmerck to F off wow
icon url

LessIsMore

10/12/22 10:51 AM

#521287 RE: iwasadiver #521279

I believe it’s quite possible Merck was recently told to “go f*** yourself” by LP

I find this to be hilarious, thanks LOL.

Any and all seasoned and unbiased investors would deduce that Merck and Moderna are teaming as competitors in the space. This is hardly good news.
icon url

HappyLibrarian

10/12/22 11:01 AM

#521300 RE: iwasadiver #521279

Ah yes that old ‘gentleman from Roche’ reference by Ms. Powers from years ago rings a bell, back when she did more presentations.

That was what constitutes exciting stuff but years later no real partnership has emerged.
icon url

beachhyena

10/12/22 2:16 PM

#521374 RE: iwasadiver #521279

Roche would be an excellent partner.
icon url

CrashOverride

10/12/22 8:10 PM

#521532 RE: iwasadiver #521279

Well said there's no need for mRNA when Dendritic cells are able to target all antigens and neoantigens.